Sort   by:  
 Page size 
UnknownClinical usefulness of anti-α3Gal immunoglobulin E assays for cetuximab-mediated anaphylaxis in head and neck cancer.
Not available
S-EPMC11919289 | biostudies-literature
UnknownFactors associated with under-reporting of head and neck squamous cell carcinoma in cause-of-death records: A comparative study of two national databases in France from 2008 to 2012.
Not available
S-EPMC7857613 | biostudies-literature
UnknownPhysical Activity Program for the Survival of Elderly Patients With Lymphoma: Study Protocol for Randomized Phase 3 Trial.
Not available
S-EPMC9736768 | biostudies-literature
UnknownLow-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
Not available
S-EPMC6530019 | biostudies-literature
UnknownStereotactic body radiation therapy for adrenal gland metastases: A multi-institutional outcome analysis.
Not available
S-EPMC10757246 | biostudies-literature
UnknownEstimating health state utility from activities of daily living in the French National Hospital Discharge Database: a feasibility study with head and neck cancer.
Not available
S-EPMC6659251 | biostudies-literature
UnknownHealth-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinoma.
Not available
S-EPMC12535876 | biostudies-literature
UnknownRandomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol.
Not available
S-EPMC10034400 | biostudies-literature
UnknownRisk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
Not available
S-EPMC7543792 | biostudies-literature
Sort   by:  
 Page size